Main Menu

Molecular Addictions Team 

Dr Igor Vivanco’s team is studying the interplay between metabolism and cancer cell signalling, with the potential for developing therapies that target these interactions.

Team leader

Dr Igor Vivanco

Dr Igor Vivanco

Team Leader in Molecular Addictions

In the last few years, Dr Vivanco has begun to characterize the molecular basis of addiction to a signalling pathway called PI3K, which is altered in the majority of human cancers.

Team members

Dr Lefteris Kostaras

Postdoctoral training fellow